SLC2A3 and gastric cancer: In pancreatic tumors, the upregulation of GLUT1 expression and increased glucose uptake was linked to the downregulation of miR-130b [51], and miR-129-5p was identified as directly targeting GLUT3 and acting as a suppressor of glucose metabolism and cell proliferation in gastric cancer (GC) cells [52].